By flow cytometry, GAL-3 was shown to bind LAMP-1 and LAMP-2 at the surface of A2058 melanoma, HT1080 fibrosarcoma, and CaCo-2 colon carcinoma cells (125). Here, LGALS3 is linked to colon carcinoma.